127 related articles for article (PubMed ID: 33499047)
1. Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells.
El Hallal R; Lyu N; Wang Y
Molecules; 2021 Jan; 26(3):. PubMed ID: 33499047
[TBL] [Abstract][Full Text] [Related]
2. Detection of genes responsible for cetuximab sensitization in colorectal cancer cells using CRISPR-Cas9.
Hu TT; Yang JW; Yan Y; Chen YY; Xue HB; Xiang YQ; Ye LC
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33048115
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer.
Li Y; Wang B; Yang W; Ma F; Zou J; Li K; Tan S; Feng J; Wang Y; Qin Z; Chen Z; Ding C
Nat Commun; 2024 Feb; 15(1):980. PubMed ID: 38302471
[TBL] [Abstract][Full Text] [Related]
4. Sertraline associated with gold nanoparticles reduce cellular toxicity and induce sex-specific responses in behavior and neuroinflammation biomarkers in a mouse model of anxiety.
Abelaira HM; de Moura AB; Cardoso MM; de Pieri E; Abel JS; Luiz GP; Sombrio EM; Borghezan LA; Anastácio RS; Cruz LA; de Souza TG; Meab C; Lima IR; da Costa C; Dal Bó AG; Pcl S; Machado-de-Ávila RA
Pharmacol Biochem Behav; 2023 Dec; 233():173661. PubMed ID: 37879445
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab produced from a goat mammary gland expression system is equally efficacious as innovator cetuximab in animal cancer models.
Wang Q; Gavin W; Masiello N; Tran KB; Laible G; Shepherd PR
Biotechnol Rep (Amst); 2020 Dec; 28():e00533. PubMed ID: 33024714
[TBL] [Abstract][Full Text] [Related]
6. HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with
Khelwatty SA; Puvanenthiran S; Essapen S; Bagwan I; Seddon AM; Modjtahedi H
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562755
[TBL] [Abstract][Full Text] [Related]
7. The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil.
da Silva WC; Godman B; de Assis Acúrcio F; Cherchiglia ML; Martin A; Maruszczyk K; Izidoro JB; Portella MA; Lana AP; Campos Neto OH; Andrade EIG
Appl Health Econ Health Policy; 2021 Jul; 19(4):557-577. PubMed ID: 33506317
[TBL] [Abstract][Full Text] [Related]
8. Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer.
Bardia A; Kaklamani V; Wilks S; Weise A; Richards D; Harb W; Osborne C; Wesolowski R; Karuturi M; Conkling P; Bagley RG; Wang Y; Conlan MG; Kabos P
J Clin Oncol; 2021 Apr; 39(12):1360-1370. PubMed ID: 33513026
[TBL] [Abstract][Full Text] [Related]
9. Melatonin increases the anticancer potential of doxorubicin in Caco-2 colorectal cancer cells.
Jadid MFS; Aghaei E; Taheri E; Seyyedsani N; Chavoshi R; Abbasi S; Khorrami A; Goleij P; Hajazimian S; Taefehshokr S; Isazadeh A; Shanehbandi D
Environ Toxicol; 2021 Jun; 36(6):1061-1069. PubMed ID: 33507000
[TBL] [Abstract][Full Text] [Related]
10. Structural control and biomedical applications of plasmonic hollow gold nanospheres: A mini review.
Guarino-Hotz M; Zhang JZ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1694. PubMed ID: 33501780
[TBL] [Abstract][Full Text] [Related]
11. Targeted Nanoparticles: the Smart Way for the Treatment of Colorectal Cancer.
Abdellatif AAH; Alshubrumi AS; Younis MA
AAPS PharmSciTech; 2024 Jan; 25(1):23. PubMed ID: 38267656
[TBL] [Abstract][Full Text] [Related]
12. Gold Nanoparticles Enhance the Tumor Growth-Suppressing Effects of Cetuximab and Radiotherapy in Head and Neck Cancer In Vitro and In Vivo.
Sato T; Kakei Y; Hasegawa T; Kashin M; Teraoka S; Yamaguchi A; Sasaki R; Akashi M
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067400
[TBL] [Abstract][Full Text] [Related]
13. Anti-Tumor Activity of Novel Nimotuzumab-Functionalized Gold Nanoparticles as a Potential Immunotherapeutic Agent against Skin and Lung Cancers.
Anisuzzman M; Komalla V; Tarkistani MAM; Kayser V
J Funct Biomater; 2023 Aug; 14(8):. PubMed ID: 37623652
[TBL] [Abstract][Full Text] [Related]
14. Functionalized Metal Nanoparticles in Cancer Therapy.
Villalobos Gutiérrez PT; Muñoz Carrillo JL; Sandoval Salazar C; Viveros Paredes JM; Gutiérrez Coronado O
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514119
[TBL] [Abstract][Full Text] [Related]
15. Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells.
Lv Y; Wang W; Liu Y; Yi B; Chu T; Feng Z; Liu J; Wan X; Wang Y
Clin Exp Metastasis; 2023 Aug; 40(4):339-356. PubMed ID: 37326719
[TBL] [Abstract][Full Text] [Related]
16. SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatment.
Lyu N; Pedersen B; Shklovskaya E; Rizos H; Molloy MP; Wang Y
Exploration (Beijing); 2022 Jun; 2(3):20210176. PubMed ID: 37323700
[TBL] [Abstract][Full Text] [Related]
17. A Recent Review on Cancer Nanomedicine.
Giri PM; Banerjee A; Layek B
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190185
[TBL] [Abstract][Full Text] [Related]
18. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
[TBL] [Abstract][Full Text] [Related]
19. Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer.
Marcelo GA; Montpeyó D; Galhano J; Martínez-Máñez R; Capelo-Martínez JL; Lorenzo J; Lodeiro C; Oliveira E
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047582
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
